CTS3497

· CytosinLab Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTS3497, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies [Phase 1, Phase 2]